84337-86-0

Basic information

• Product Name: 4'-BroMo[1,1'-biphenyl]-4-Methanol,4-(4-broMophenyl)phenyl-Methanol
• Synonyms: 4'-BroMo[1,1'-biphenyl]-4-Methanol,4-(4-broMophenyl)phenyl-Methanol
• CAS NO: 84337-86-0
• Molecular Formula: C₁₃H₁₁BrO
• Molecular Weight: 263.12984
• Mol File: 84337-86-0.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4'-BroMo[1,1'-biphenyl]-4-Methanol,4-(4-broMophenyl)phenyl-Methanol(CAS DataBase Reference)
• NIST Chemistry Reference: 4'-BroMo[1,1'-biphenyl]-4-Methanol,4-(4-broMophenyl)phenyl-Methanol(84337-86-0)
• EPA Substance Registry System: 4'-BroMo[1,1'-biphenyl]-4-Methanol,4-(4-broMophenyl)phenyl-Methanol(84337-86-0)

Safety Data

• Hazardous Substances Data: 84337-86-0(Hazardous Substances Data)

Upstream product

• 59016-93-2 p-hydroxymethylphenylboronic acid 
• 177490-72-1 (4-Bromo-phenyl)-chloromethoxymethyl-dimethyl-silane 
• 50670-58-1 4-formyl-4'-bromobiphenyl 
• 92-86-4 4-(4-bromophenyl)bromobenzene 
• 106-37-6 1.4-dibromobenzene 
• 17902-37-3 1-bromo-4-[(chloromethyl)dimethylsilyl]benzene 
• 177490-81-2 [(4-Bromo-phenyl)-dimethyl-silanyl]-methanol 
• 177490-80-1 Acetic acid [(4-bromo-phenyl)-dimethyl-silanyl]-methyl ester 
• 50670-49-0 4-bromo-4'-methylbiphenyl 
• 50670-57-0 4-bromo-4'-(bromomethyl)-1,1'-biphenyl 
• 89901-03-1 methyl 4’-bromo-[1,1’-diphenyl]-4-carboxylate 
• 589-87-7 1,4-bromoiodobenzene 
• 619-44-3 methyl 4-iodobenzoate 
• 5467-74-3 4-Bromophenylboronic acid 

Downstream Products

• 91587-09-6 4-<4-(2,6,6-trimethylcyclohexenyl)phenyl>benzoic acid 
• 91587-34-7 4'-(2,6,6-Trimethyl-cyclohex-1-enyl)-biphenyl-4-carboxylic acid methyl ester 
• 91587-33-6 methyl 4-<4-(1-hydroxy-2,2,6-trimethylcyclohexyl)phenyl>benzoate 
• 50670-57-0 4-bromo-4'-(bromomethyl)-1,1'-biphenyl 
• 1006378-59-1 (4'-(hydroxymethyl)biphenyl-4-yl)triphenylphosphonium bromide 
• 1296273-07-8 ({[5-hydroxy-2-({1-[4’-(hydroxymethyl)biphenyl-4-yl]piperidin-4-yl}methyl)-6-methylpyrimidin-4-yl]carbonyl}amino)acetic acid 
• 1296273-08-9 ({[2-{(1-[4'-(acetoxymethyl)biphenyl-4-yl]piperidin-4-yl}methyl)-5-hydroxy-6-methylpyrimidin-4-yl]carbonyl}amino)acetic acid 
• 1296273-64-7 tert-butyl 5-(benzyloxy)-2-{(1-[4'-({[tert-butyl(dimethyl)silyl]oxy}methyl)biphenyl-4-yl]piperidin-4-yl}methyl)-6-methylpyrimidine-4-carboxylate 
• 1296273-65-8 tert-butyl 5-(benzyloxy)-2-{(1-[4'-(hydroxymethyl)biphenyl-4-yl]piperidin-4-yl}methyl)-6-methylpyrimidine-4-carboxylate 
• 1296273-67-0 5-(benzyloxy)-2-{(1-[4'-(hydroxymethyl)biphenyl-4-yl]piperidin-4-yl}methyl)-6-methylpyrimidine-4-carboxylic acid 
• 1296273-66-9 ethyl ({[5-(benzyloxy)-2-({1-[4'-(hydroxymethyl)biphenyl-4-yl]piperidin-4-yl}methyl)-6-methylpyrimidin-4-yl]carbonyl}amino)acetate 
• 1296274-30-0 4-{[2-(benzyloxy)-2-oxoethyl]carbamoyl}-2-{[1-(4'-{[(2,2-dimethylpropanoyl)oxy]methyl}biphenyl-4-yl)piperidin-4-yl]methyl}-6-methylpyrimidin-5-yl pivalate 
• 1296274-29-7 benzyl ({[5-hydroxy-2-({1-[4'-(hydroxymethyl)biphenyl-4-yl]piperidin-4-yl}methyl)-6-methylpyrimidin-4-yl]carbonyl}amino)acetate 
• 1296274-39-9 ethyl ({[5-(benzyloxy)-2-{[1-(4'-formylbiphenyl-4-yl)piperidin-4-yl]methyl}-6-methylpyrimidin-4-yl]carbonyl}amino)acetate 

Relevant articles and documents

Functionalised phosphonate ester supported lanthanide (Ln = La, Nd, Dy, Er) complexes

A series of phosphonate ester supported lanthanide complexes bearing functionalities for subsequent immobilisation on semiconductor surfaces are prepared. Six phosphonate ester ligands (L1-L6) with varying aromatic residues are synthesised. Subsequent com

PHENYL SUBSTITUTED CARBOXYLIC ACIDS

Disclosed are compounds and pharmaceutically acceptable salts of formula (A): which are useful in the treatment of metabolic disorders related to insulin resistance, leptin resistance, or hyperglycemia. Compounds of the invention include inhibitors of Protein tyrosine phosphatases, in particular Protein tyrosine phosphatase-1B (PTP-1B), that are useful in the treatment of diabetes and other PTP mediated diseases, such as cancer, neurodegenerative diseases and the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.

PHENYL SUBSTITUTED CARBOXYLIC ACIDS

Disclosed are compounds and pharmaceutically acceptable salts of formula (A): which are useful in the treatment of metabolic disorders related to insulin resistance, leptin resistance, or hyperglycemia. Compounds of the invention include inhibitors of Protein tyrosine phosphatases, in particular Protein tyrosine phosphatase-1B (PTP-1B), that are useful in the treatment of diabetes and other PTP mediated diseases, such as cancer, neurodegenerative diseases and the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.